Stocktoria
TRANSCAT INC TRNS
TRANSCAT INC (TRNS) earns a Piotroski F-score of 5/9 (mixed financial health), with an Altman Z″ in the safe zone. It does not currently pay a dividend. FY2026 revenue was $331.9M at a 1.6% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.78 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 5/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.11 |
| Retained earnings / assets | 0.203 |
| EBIT / assets | 0.028 |
| Equity / liabilities | 1.671 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| TRNS | TRANSCAT INC | 5/9 | 3.32 | 160.2 | +19.2% |
| COHU | COHU INC | 4/9 | 5.27 | — | +12.7% |
| INTT | INTEST CORP | 4/9 | 4.89 | — | -12.9% |
| ALNT | ALLIENT INC | 4/9 | 4.86 | — | +4.6% |
| FEIM | FREQUENCY ELECTRONICS INC | 3/9 | 3.56 | — | -9.4% |
| AEHR | AEHR TEST SYSTEMS | 2/9 | 12.12 | — | -15.2% |
| DAIO | DATA I/O CORP | 2/9 | 2.64 | — | -1.2% |
About TRANSCAT INC
Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. The company operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management system that is used to manage the workflow of its calibration service centers and customers' assets; and Compliance, Control, and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs, as well as value-added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense, industrial manufacturing, energy and utilities, oil and gas, chemical manufacturing, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York.
FAQ
Is TRNS financially healthy?
TRANSCAT INC's Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does TRNS pay a dividend?
No, TRANSCAT INC does not currently pay a dividend.
How profitable is TRNS?
In FY2026, TRANSCAT INC had a net margin of 1.6% and a return on equity of 1.8%.
Is TRNS overvalued or undervalued?
TRANSCAT INC trades at about 171.5× trailing earnings — above its 10-year norm (10-year range 19.1×–133.5×, median 48.7×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for TRNS?
The average Wall-Street price target for TRANSCAT INC is $101.33, about 3.7% above the recent price, from 3 analysts.
Is TRNS a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on TRANSCAT INC: a Piotroski F-score of 5/9, an Altman Z″ in the safe zone, a P/E of about 160.2×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2026-03-28. Facts plus Stocktoria's own computed scores — not investment advice.